In the present study, we demonstrated the association between specific KRAS mutations and the density of TILs by whole-slide image analysis in a homogeneous cohort of stage III CRC patients who received adjuvant FOLFOX chemotherapy. This evidence concerns the gene KRAS and colorectal carcinoma.